Amwell makes grant to new employees under inducement plan
Amwell (NYSE: AMWL), a technology-enabled care platform provider, has granted 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (NYSE: AMWL), a technology-enabled care platform provider, has granted 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements. The RSUs follow a four-year vesting schedule, with 25% vesting after one year and the remaining 75% vesting quarterly over three years.
The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, complying with NYSE's Listed Company Manual Rule 303A.08.
Positive
- Equity-based compensation aligns new employee interests with shareholders
- Structured vesting schedule helps retain talent for 4 years
Negative
- Potential dilution from 76,198 new shares
Details
News Market Reaction – AMWL
On Aug 11, the first trading day after this news, AMWL closed 1.51% below the previous close.
Data tracked by StockTitan Argus for the Aug 11 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date:
The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to the Amwell’s Inducement Plan and made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Amwell is issuing this press release pursuant to Rule 303A.08.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Media:
Press@amwell.com
Investor:
Sue Dooley
Sue.Dooley@amwell.com
Notice of Ownership
All materials contained herein are the property of American Well Corporation and are copyrighted under United States law and applicable international copyright laws and treaty provisions. The materials contained herein are not work product or "work for hire" on behalf of any third party. The materials contained herein constitute the confidential information of American Well Corporation, except for specific data elements provided by third parties, which are the confidential information of such third parties. The content contained herein results from the application of American Well proprietary processes, analytical frameworks, algorithms, business methods, solution construction aids and templates, all of which are and remain the property of American Well Corporation.
Trademark Notice
All of the trademarks, service marks and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of American Well Corporation or third parties who have licensed their Trademarks to American Well Corporation. Except as expressly stated in these terms and conditions, you may not reproduce, display or otherwise use any Trademark without first obtaining American Well Corporation's written permission.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.